MedTrace Logo

INvestigating SIGnificant Health TrendS in the Management of Superficial Vein Thrombosis

NCT02699151 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1210

Last updated 2023-09-14

No results posted yet for this study

Summary

Superficial vein thrombosis (SVT) and venous thromboembolism (VTE) are related entities. Only in the last years a series of observational studies mainly conducted in France could show that ´isolated SVT´ (without concomitant deep vein thrombosis and/or pulmonary embolism) is in fact not a benign and spontaneously healing disease but bears a potential for severe thromboembolic complications once not treated adequately. INSIGHTS-SVT study aims at collecting representative data on the current management and outcomes of SVT in Germany under real-life conditions. It will document the implementation of the recently issued national SVT guidelines issued by the Society for Angiology (DGA) and the Society for Phlebology (DGP).

Conditions

  • Superficial Vein Thrombosis

Interventions

DRUG

any drug

Any drug used for the treatment of SVT (e.g. heparin, low-molecular heparin, non-steroidal anti-inflammatory drug, fondaparinux, vitamin K antagonist)

PROCEDURE

any procedure/surgery

Any procedure used for the treatment of SVT(e.g. sclerotherapy, endovenous thermotherapy, crossectomy, stripping, thrombectomy, phlebectomy)

OTHER

Any non-pharmacological treatment of SVT

Any non-pharmacological treatment of SVT (including watchful waiting)

Sponsors & Collaborators

  • GWT-TUD GmbH

    lead OTHER

Principal Investigators

  • Rupert Bauersachs, MD · Gefäßzentrum, Klinikum Darmstadt

  • David Pittrow, MD · GWT-TUD GmbH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-14
Primary Completion
2019-08-30
Completion
2019-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02699151 on ClinicalTrials.gov